Medical network - on November 11, is the world's second largest medical market in China, according to China association of medical supplies medical equipment branch, 2015 national medical apparatus and instruments market size of 300 billion yuan of above, the average growth rate of 20.05%.

In the above data, import medical instrument $17.319 billion, up 9.81% from a year earlier, up 4.49% growth. 43 varieties of medical equipment imports more than $100 million, compared with eight varieties increased. Large advanced diagnostic equipment such as CT, MRI (magnetic resonance imaging (MRI), nuclear medicine, and vascular ZaoYingJi DSA has long been "GPS" (i.e., GE American GE, Philips, the Dutch Philips, Siemens Germany Siemens) such as monopoly by foreign giants. 2014 "GPS" to the above four kind of product in our country, the market share reached 83.3%, 85.7%, 87.9% and 85.7%, respectively, in 2015 to keep more than 85% of the share.

Multinational medical device companies use market monopoly, and constantly raise price products and after-sales service. Heart stents, for example, domestic and imported stents in little difference on the technology, but domestic and imported on the bidding and pricing will be 1 to 2 times the gap. The same cardiac pacemaker domestic bidding price price 15% to 20% higher than that of abroad. In the field of aftermarket and consumables, imported medical instruments year warranty from more than a decade ago accounted for 6% of contract price soared to nearly 15% today. In a foreign brand nuclear magnetic resonance instrument, for example, the Chinese market sales price contain intermediate premiums in 1 million - 2 million yuan a year. High purchase and maintenance costs for medical and health institutions economic pressure, and increase the patient's medical treatment cost. In addition, high-end medical equipment core technology in foreign enterprises, medical diagnosis and treatment of the data and the patients medical records and other information security is also at risk.

"Made in China 2025" has clearly put forward to improve the innovative ability of medical equipment and the level of industrialization, focus on developing high performance medical device, gradually get rid of the situation of high-end medical equipment imports. At present, the overall level of science and technology and domestic equipment 10 years gap between developed countries or regions, mainly reflected in the enterprise scale is small, less competitive; Research and development funding; Domestic medical institutions to purchase and use of domestic equipment supporting policies are inadequate; National overall is somewhat weak industrial base, etc. How over the next ten years (2025) quickly catch up with foreign advanced level and scale, medical equipment industry to break through?

First of all, should establish production, study and research, medical collaborative innovation mechanism. Aggregation of science and technology and capital concentration is the key to medical equipment industry by the big teams, need the international first-class level of scientific research team, industry leading and high levels of risk investment project docking, leading to high-end medical equipment. To strengthen the cooperation with a high level of scientific research institutes and national scientific research project application to industry, the formation of complementary advantages, the effective use of resources. Between domestic enterprises should also strengthen the transverse joint, build intellectual property alliance, cross licensing patents, Shared patent rights, etc., set the length of each, common to improve the overall level of the industry, echo supply side national strategy of reform. To support conditional domestic enterprises to go out and participate in international mergers and acquisitions, in the field of edge quickly narrow the gap with foreign, industry leading. In addition, the clinical demand is the biggest motivation and source of innovation of medical equipment, find inspiration and breakthrough from the frontline staff is also one of the most important aspects of the innovation of medical equipment research and development.

Second, strengthen the top-level design, implement around key breakthroughs. According to the "made in China 2025" strategy, focus on medical robot, wearable medical devices, mobile and remote diagnosis and treatment, radiation therapy, and other fields to promote. From the macroscopic level, should develop much starker choices-and graver consequences-in planning medical equipment innovation development in our country and other industry development plan, clear development goals and policies and measures to seize the new frontier exploration research, coordination of efforts to accelerate the domestic medical equipment industry innovation and scientific and technological progress.

Again, increase investment in r&d and technical reserves. R&d investment in the domestic medical equipment industry due to factors such as individual scale lasts only about 3%. Industry analysis, according to the nation's largest two mindray medical instrument company and diving researching total only 2014, 2014 and 910 million and "GPS" in the same period in 8.06 billion, 6.62 billion and 8.44 billion respectively. Global medical device r&d spending in 2015 accounted for 6.35% of sales revenue, the developed countries and even reached 15%. On the number of patents "GPS" patent number 2014 to 7840, the domestic leading the mindray medical only 150 patents.

Furthermore, to speed up the implementation of talent strategy, cultivate a large number of proficient in materials science and engineering science, clinical medicine of compound talents, gradually improve clinical engineering personnel in the proportion of medical and health technical personnel. While encouraging domestic enterprises, and other forms of "introduction to walk out" to strengthen international cooperation, to absorb the international first-class research and development team and talent.

In addition, perfect the innovative medical device regulatory policy, encourage innovation. Has to implement the innovation of the medical equipment special approval process, the average time for 37 days, than ordinary products to accept the time to save more than 60%. Using risk analysis and adjusting the product categories of medical equipment, will mature security risk controllable product registration approval, perfecting the relevant measures to solve the congestion problem of examination and approval. On the premise of guarantee the listed product is safe and effective, with core invention patent, is an international leading level of technical innovation in the preferred examination and approval, patent protection, preferential subsidies, etc to give more policy support.

Finally, to keep up with the development trend of health care management informatization and networking. Innovation in developing high-end medical equipment, to break the foreign capital giant monopoly should attach great importance to "Internet +" thinking, through integration of resources, foster medical equipment + medical service field, including medical equipment + Internet, data processing center + independent software, clinical samples + personalized products such as sharing medical. Our country has the world's largest population, in the process of innovative medical devices hold good big data is applied, will become a unique advantage of domestic high-end medical equipment.